|Non-ECA Members:||EUR 1690,--|
|ECA Members:||EUR 1490,--|
|EU GMP Inspectorates:||EUR 845,--|
|APIC Members (does not include ECA membership):||EUR 1590,--|
Alle Preise zzgl. MwSt.
Tel.: 06221 / 84 44 0 E-Mail: email@example.com
During this course, you will get to know the principles and discuss all relevant aspects to implement and/ or work with a Deviation Management and CAPA System. Furthermore, you will get to know possibilities and tools to monitor and evaluate your CAPAs.
Things will go wrong from time to time. In the world of pharmaceuticals, we need to ensure that we have robust processes and procedure in place to deal with such situations. When an unplanned event arises it must be handled accordingly.
FDA’s Quality System Guide, recent Warning Letters and EU-GMP Chapter 1 clearly emphasise the increasing relevance of a proper deviation management and
CAPAs. ICH Q9 on Quality Risk Management and ICH Q10 on Pharmaceutical Quality Systems empower us to handle issues that arise in our daily work on the basis of risk analysis.
In any case a sound failure investigation is the key. Here it is also important to know how to deal with human error based and non-human error based non-conformances. Effective root cause analysis is the key to identifying appropriate CAPAs.
Independent from that, it needs to be pointed out that CAPA is an excellent Quality Management tool to continuously improve processes and avoid future failures. All personnel involved in the management of deviations and in CAPAs should aim to identify opportunities for further improvement.
This course is designed for all personnel involved in Deviation Management and CAPA activities at their company. It is addressed to persons from Quality Assurance and Control, Manufacturing and R&D.
International Requirements – Rules and Regulations